Daily Management Review

Pfizer & Merck’s Joint Venture In Diabetes Drug Gets EMA Committee’s Recommendation


01/27/2018


Steglatro will be treating type II diabetes orally.



One panel of European Medicines Agency, shortly called EMA, has come up with a recommendation of “granting marketing approval” towards a drug for diabetes that has been jointly developed by Merck & Co and Pfizer Inc.
 
The said recommendation of the EMA panel for “Medicinal Products for Human Use” can be a booster to the European Commission bound companies. The drug, an oral treatment used for treating “Type II diabetes”, will be coming to the market under the name of Steglatro.
 
Steglatro is a “SGLT2 inhibitors” which will help the patients’ “excess glucose” to be expelled “through urine”. While Reuters added:
“In December, Merck and Pfizer won approval from the U.S. Food and Drug Administration for Steglatro as a single therapy and in fixed-dose combinations with Merck’s diabetes drug Januvia or with metformin, an older generic treatment typically given to newly diagnosed patients”.
 
Diabetes can cause severe organ damage affecting the “eyes and kidneys” besides it can also raise significant risk of “heart attack and stroke”. With the progression of “type II diabetes” many patients require “additional treatments” to keep their “blood sugar levels” under “better control”.
References:
reuters.com







Science & Technology

Porsche, Boeing set to develop flying electric car

Samsung to invest $ 11 billion in new generation displays

US is betting on Nokia and Ericsson to replace Huawei

UPS becomes first to receive full regulatory approval for UAV shipping in USA

NASA orders Lockheed Martin to build spacecraft to fly to the Moon

Hyundai to create joint venture for unmanned vehicles

Bain & Company: E-wallets and cheaper transactions are new payment trends

Is UAV drone industry falling into decay?

UK Scotland Yard employs AI to deal with frauds

US sets to fight robocalls outbreak

World Politics

World & Politics

France: We will take measures to protect our military in Syria

Paralyzed Hong Kong: Protests don't fade

Johnson unveils Brexit compromise deal considering Irish issue

African swine fever at Europe’s borders: time for an embargo?

Saudi Crown Prince Says Khashoggi’s Murder Happened Under His Watch

Will Merkel restore her "Climate Chancellor" image?

Venezuelan opposition to receive $ 52 mln from USA

US And Saudi Threatened By Iranian Commanders In Case Of An Attack On Tehran